Deerfield Management Company, L.P. (Series C) Boston Scientific Corp Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $110 Million - $126 Million	-2,857,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$35.27 - $39.67 $86.4 Million - $97.2 Million	2,450,000 Added 601.97%	2,857,000 $110 Million
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $13.5 Million - $17.1 Million	407,000 New	407,000 $14.6 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

Vanguard Group Inc Valley Forge, PA

131M
Shares

$11.9 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

126M
Shares

$11.4 Billion
0.22% of portfolio
State Street Corp Boston, MA

62.8M
Shares

$5.69 Billion
0.22% of portfolio
Primecap Management CO Pasadena, CA

37.8M
Shares

$3.43 Billion
2.37% of portfolio
Wellington Management Group LLP Boston, MA

32.8M
Shares

$2.97 Billion
0.49% of portfolio

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account